HomeNDC LookupRxCUI directory › RxCUI 864718

Methadone hydrochloride 5 MG Oral Tablet — RxCUI 864718

RxNorm drug concept · Semantic clinical drug
RxCUI 864718 Semantic clinical drug · SCD ● Current RxNorm concept 16 FDA products 26 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI864718
Official nameMethadone hydrochloride 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmethadone HCl 5 MG Oral Tablet
FDA products mapped16
Package NDCs mapped26
Reported Medicaid activity (SDUD)67,066 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methadone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Methadone is reserved for severe, persistent pain that needs around-the-clock treatment and hasn't responded well to other options. It's a long-acting opioid, which means it works...
  • Why is my doctor prescribing methadone instead of a regular painkiller?
  • When methadone is used for opioid addiction — not pain — federal law requires it to be dispensed only through certified opioid treatment programs. These clinics follow strict safet...
  • Why does methadone need to be dispensed at a special clinic for opioid treatment?
📖 Read our full Methadone guide →

🕸️ Concept Web — How Methadone hydrochloride 5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Methadone hydrochloride 5 MG Oral Tablet RxCUI 864718

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Methadone 6813
    • Methadone hydrochloride 218337
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Dolophine 202370
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Methadone Oral Tablet 372808
    • Methadone hydrochloride Oral Tablet 2649131
    • Methadone Oral Product 1161621
    • Methadone Pill 1161622
    • Methadone hydrochloride Oral Product 2663074
    • Methadone hydrochloride Pill 2661548
    • Methadone Oral Tablet [Dolophine] 368847
    • Methadone hydrochloride Oral Tablet [Dolophine] 2654639
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Methadone hydrochloride 5 MG 864717
    • Methadone hydrochloride 5 MG Oral Tablet [Dolophine] 864720
    • Methadone hydrochloride 5 MG [Dolophine] 864719

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Methadone hydrochloride 5 MG SCDC · 864717
  • Methadone Oral Tablet SCDF · 372808
  • Methadone hydrochloride Oral Tablet SCDFP · 2649131
  • Methadone Oral Product SCDG · 1161621
  • Methadone Pill SCDG · 1161622
  • Methadone hydrochloride Oral Product SCDGP · 2663074
  • Methadone hydrochloride Pill SCDGP · 2661548

Brand-Name Concepts

  • Methadone hydrochloride 5 MG Oral Tablet [Dolophine] SBD · 864720
  • Methadone hydrochloride 5 MG [Dolophine] SBDC · 864719
  • Methadone Oral Tablet [Dolophine] SBDF · 368847
  • Methadone hydrochloride Oral Tablet [Dolophine] SBDFP · 2654639
  • Dolophine Oral Product SBDG · 1174574
  • Dolophine Pill SBDG · 1174575
  • Dolophine BN · 202370

📦 FDA Products & Package NDCs

16 products · 26 package NDCs
26 package NDCs map to RxCUI 864718 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-0709-20 1 BLISTER PACK in 1 CARTON (0054-0709-20) / 100 TABLET in 1... METHADONE HYDROCHLORIDE Hikma Pharmaceuticals USA Inc. 1983-03-08
00054-0709-25 100 TABLET in 1 BOTTLE, PLASTIC (0054-0709-25) METHADONE HYDROCHLORIDE Hikma Pharmaceuticals USA Inc. 1983-03-08
00054-0710-20 1 BLISTER PACK in 1 CARTON (0054-0710-20) / 100 TABLET in 1... METHADONE HYDROCHLORIDE Hikma Pharmaceuticals USA Inc. 1983-03-08
00054-0710-25 100 TABLET in 1 BOTTLE, PLASTIC (0054-0710-25) METHADONE HYDROCHLORIDE Hikma Pharmaceuticals USA Inc. 1983-03-08
00406-5755-01 100 TABLET in 1 BOTTLE (0406-5755-01) METHADONE HYDROCHLORIDE SpecGx LLC 2004-04-27
00406-5755-23 1 TABLET in 1 BLISTER PACK (0406-5755-23) METHADONE HYDROCHLORIDE SpecGx LLC 2004-04-27
00406-5755-62 100 TABLET in 1 BLISTER PACK (0406-5755-62) METHADONE HYDROCHLORIDE SpecGx LLC 2004-04-27
00406-5771-01 100 TABLET in 1 BOTTLE (0406-5771-01) METHADONE HYDROCHLORIDE SpecGx LLC 2004-04-27
00406-5771-23 1 TABLET in 1 BLISTER PACK (0406-5771-23) METHADONE HYDROCHLORIDE SpecGx LLC 2004-04-27
00406-5771-62 100 TABLET in 1 BLISTER PACK (0406-5771-62) METHADONE HYDROCHLORIDE SpecGx LLC 2004-04-27
13107-0088-01 100 TABLET in 1 BOTTLE (13107-088-01) Methadone Hydrochloride Aurolife Pharma, LLC 2015-09-15
13107-0088-30 30 TABLET in 1 BOTTLE (13107-088-30) Methadone Hydrochloride Aurolife Pharma, LLC 2015-09-15
13107-0088-99 1000 TABLET in 1 BOTTLE (13107-088-99) Methadone Hydrochloride Aurolife Pharma, LLC 2015-09-15
13107-0089-01 100 TABLET in 1 BOTTLE (13107-089-01) Methadone Hydrochloride Aurolife Pharma, LLC 2015-09-15
13107-0089-30 30 TABLET in 1 BOTTLE (13107-089-30) Methadone Hydrochloride Aurolife Pharma, LLC 2015-09-15
13107-0089-99 1000 TABLET in 1 BOTTLE (13107-089-99) Methadone Hydrochloride Aurolife Pharma, LLC 2015-09-15
31722-0946-01 100 TABLET in 1 BOTTLE (31722-946-01) Methadone Hydrochloride Camber Pharmaceuticals, Inc 2019-01-03
31722-0947-01 100 TABLET in 1 BOTTLE (31722-947-01) Methadone Hydrochloride Camber Pharmaceuticals, Inc 2019-01-03
42806-0317-01 100 TABLET in 1 BOTTLE (42806-317-01) Methadone Hydrochloride Epic Pharma, LLC 2018-06-11
42806-0318-01 100 TABLET in 1 BOTTLE (42806-318-01) Methadone Hydrochloride Epic Pharma, LLC 2018-06-11
64850-0603-01 100 TABLET in 1 BOTTLE, PLASTIC (64850-603-01) Methadone Hydrochloride Elite Laboratories, Inc. 2018-08-06
64850-0604-01 100 TABLET in 1 BOTTLE, PLASTIC (64850-604-01) Methadone Hydrochloride Elite Laboratories, Inc. 2018-08-06
67877-0659-01 100 TABLET in 1 BOTTLE (67877-659-01) Methadone Hydrochloride Ascend Laboratories, LLC 2025-07-01
67877-0660-01 100 TABLET in 1 BOTTLE (67877-660-01) Methadone Hydrochloride Ascend Laboratories, LLC 2025-07-01
72865-0120-01 100 TABLET in 1 BOTTLE (72865-120-01) Methadone Hydrochloride XLCare Pharmaceuticals, Inc 2019-01-03
72865-0121-01 100 TABLET in 1 BOTTLE (72865-121-01) Methadone Hydrochloride XLCare Pharmaceuticals, Inc 2019-01-03
Observed labelers: Aurolife Pharma, LLC (6) · SpecGx LLC (6) · Hikma Pharmaceuticals USA Inc. (4) · Ascend Laboratories, LLC (2) · Camber Pharmaceuticals, Inc (2) · Elite Laboratories, Inc. (2) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.